Sort
15,842 grants matching “pancreatic cancer”
Deiminated molecules as markers for developing pancreatic cancer - A1
$182,909Peter Storz · Mayo Clinic Jacksonville · R21 · FY2024 · CA
New Thermal Sensitive Carboplatin Liposome for Cancer
$182,906Robert A. Reed · Celsion Corporation · R43 · FY2010 · CA
Project 6 - Development of Metabolically Active Linkers (MALs) to Improve Diagno
$182,889Jered C Garrison · University Of Nebraska Medical Center · P20 · FY2014 · GM
Giant Macrophage-like Cells as a blood-based Biomarker for Lung Cancer Recurrence
$182,850Daniel L. Adams · Creatv Microtech, Inc. · R43 · FY2017 · CA
Autophagy in Pancreatic Neuroendocrine Tumor Growth and Metastasis
$182,799Yi-Chieh Nancy Du · Weill Medical Coll Of Cornell Univ · R21 · FY2014 · CA
Genetic technology development for elucidating lineage plasticity mechanisms in cancer
$182,755Damianos S. Skopelitis · Cold Spring Harbor Laboratory · R50 · FY2025 · CA
TARGETED DELIVERY OF GENES TO ANGIOGENIC VASCULATURE
$182,712University Of Texas Md Anderson Can Ctr · R01 · FY2004 · CA
The Role of Myc in ChREBP-dependent, Glucose-stimulated Gene Expression
$182,709Donald K Scott · University Of Pittsburgh At Pittsburgh · R56 · FY2010 · DK
IDO-silencing Salmonella therapy for the treatment of primary and metastatic PDAC
$182,700Don J Diamond · Beckman Research Institute/City Of Hope · R21 · FY2013 · CA
THE INFLAMMATORY RESPONSE OF THE PANCREATIC ACINAR CELL
$182,637Stephen J Pandol · University Of California Los Angeles · R01 · FY2006 · DK
Collagen XV as a tumor and metastasis suppressor.
$182,539Ann Harris · Lurie Children'S Hospital Of Chicago · R21 · FY2007 · CA
Non-invasive sampling of DNA markers for pancreatic cancer screening
$182,488Yu-Tsueng Liu · University Of California, San Diego · R21 · FY2013 · CA
Novel immunotherapy strategy for treatment of pancreatic cancer
$182,461Pinku Mukherjee · Oncotab, Inc · R41 · FY2016 · CA
CLINICAL TRIALS CORE
$182,410Tomislav Dragovich · University Of Arizona · P01 · FY2008 · CA
A Lectin Glycoarray Approach for Markers of Pancreatic Cancer
$182,400David M. Lubman · University Of Michigan At Ann Arbor · R21 · FY2008 · CA
Tissue Resource and Molecular Pathology Core
$182,350William E. Grizzle · University Of Alabama At Birmingham · P50 · FY2014 · CA
P4 - ATDC as a Therapeutic Target in Pancreatic Cancer
$182,317Diane M Simeone · University Of Michigan At Ann Arbor · P50 · FY2010 · CA
Mechanism-Based Design of Combination Therapies for Pancreatic Cancer
$182,268Tayyaba Hasan · Massachusetts General Hospital · P01 · FY2011 · CA
Career Enhancement Program
$182,195William E Gillanders · Washington University · P50 · FY2024 · CA
Armed oncolytic parvoviral vectors for modulating the tumor microenvironment
$182,156Peter Tattersall · Yale University · R21 · FY2019 · CA
KRas Ligand Development
$182,156Craig M Crews · Yale University · R21 · FY2017 · CA
Role of Telmisartan on Intra-Tumoral Distribution of Targeted Nanoparticles
$182,126Mandip Singh Sachdeva · Florida Agricultural And Mechanical Univ · R21 · FY2014 · CA
The Role of AGR2 in a Murine Model of Pancreatic Adenocarcinoma
$182,116Anson W Lowe · Stanford University · R21 · FY2011 · CA
Target Validation using Gene Knockouts in Somatic Cells
$182,024Pangenex, Inc. · R44 · FY2003 · CA
KS1, A NOVEL SUPPRESSOR OF NEOPLASTIC TRANSFORMATION
$182,019Mayo Clinic Coll Of Medicine, Rochester · R01 · FY2001 · DK